Jane Adams is the vice president of federal government affairs and Canada at Johnson & Johnson, where she manages a team of DC-based federal lobbyists as well as the Canada government affairs team.

Adams is responsible for policy initiatives, including innovation, tax, trade, veterans’ issues, corporate responsibility, and branding with federal policymakers.

Adams has worked for more than 30 years in public health and biomedical research policy as well as in patient advocacy and public affairs. She has led efforts on behalf of the medical technology industry and the US healthcare community in roles at Medtronic, the type 1 diabetes advocacy group JDRF, and the National Association for Biomedical Research.

Adams led J&J efforts on legislation, including the Medicare Modernization Act, the Affordable Care Act, 21st Century Cures, and drug and device user fee-reform packages and 2017’s tax-cut bill.

Todd Askew was recently named the senior vice president of advocacy at the American Medical Association (AMA) overseeing all legislative, regulatory and health policy issues at the biggest lobbying group for doctors.

Previously, Askew served as the director of congressional affairs for more than 13 years at the AMA.

Before joining the AMA, Askew served as a legislative aide for the American Academy of Pediatrics Department of Federal Affairs. In this role, he worked on healthcare financing and public health, including the 1997 enactment of the Children’s Health Insurance Program.